Publications
Back to News and Media

IAM1363-01: A Phase 1/1b Study of a Selective and Brain-Penetrant HER2 Inhibitor for HER2-Driven Solid Tumors

Publications
This is some text inside of a div block.
June 1, 2024

Media Contacts

Related announcements

View All
View All
May 11, 2026

Iambic to participate in upcoming investor conferences

Read more
May 11, 2026

Iambic to participate in upcoming investor conferences

Read more
April 2, 2026

Iambic to Participate in April Investor Conferences

Read more
April 2, 2026

Iambic to Participate in April Investor Conferences

Read more
March 2, 2026

Iambic to Participate in March Investor Conferences

Read more
March 2, 2026

Iambic to Participate in March Investor Conferences

Read more